Table 2.
Average daily intake (ADI), average daily weight gain (ADWG) and feed efficiency coefficient (FEC) of experimental animals during the second stage of treatment and average weight of epididymal adipose tissue (g) and the liver (g) at the end of the study followed by the coefficient of variation expressed as a percentage (CV%)
| Group | Dietary intake control | Liver (g) | Epididymal adipose tissue (g) | ||
|---|---|---|---|---|---|
| ADI (g) | ADWG (g) | FEC | |||
| 1 (diet A) | 22.90a | 1.87b | 0.094b,c | 8.15 | 5.11b |
| 2 (diet B) | 18.79a,b,c | 2.22a | 0.130a | 8.36 | 5.65b |
| 3 (diet C) | 17.99a,b,c | 1.94a,b | 0.102b | 8.29 | 1.69a |
| 4 (diet D) | 16.11b,c | 1.70b,c | 0.098b,c | 6.56 | 1.88a |
| 5 (diet E) | 20.27a,b | 1.30d | 0.073d | 6.71 | 1.48a |
| 6 (diet F) | 14.86c | 1.45c,d | 0.084c,d | 7.54 | 1.75a |
| CV% | 16.86 | 29.83 | 10 | 15.8 | 26.2 |
Group 1 (standard diet), group 2 (diet with high glucose levels, 31.5%), group 3 (diet with high glucose levels and 15% toasted quinoa flour), group 4 (diet with high glucose levels and 15% sprouted and toasted quinoa flour), group 5 (diet with high glucose levels and 15% fermented and toasted quinoa flour) and group 6 (diet with high glucose levels and 15% sprouted/fermented and toasted quinoa flour). Means followed by the same letter in columns are not significantly different from each other according to Tukey’s test at 5% significance